Employer-Paid

Employer costs for GLP-1 agonists and similar drugs could end up averaging $3.17 to $22.88 per enrollee per month.

A New York state judge dismissed the most serious charges against Luigi Mangione but allowed some murder counts to stand.

While recent changes can be seen as an opportunity for long-term savers, these developments add complexity and liability to advisors and employers managing retirement plans.

Employers here may have a harder time bargaining with the providers and policymakers.

Stop-loss issuers have been talking for more than a year about seeing a broad, powerful surge in claims.

UnitedHealth Group has stepped up its lobbying efforts targeting the Trump administration as it seeks to rebound from numerous lawsuits and regulatory issues that have caused its market value to decline by 40% since April.